Among the 59 preparations that had not been significantly more purchased there were 17 different individual diabetes medications (p = 0.017–0.323), the channel blocker amlodipine (22.5% vs 18.8%, p = 0.076), ACE-inhibitor enalapril (25.6% vs 21.3%, p = 0.056), disulfiram (1.4% vs 0.7%, p = 0.097), analgesic morphine, and antispasmodics (2.5%–1.5%, p = 0.114). Here, ACE is linked to diabetes mellitus.